H.C. Wainwright initiated coverage on ASP Isotopes with a new price target
$ASPI
Major Chemicals
Industrials
H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/4/2024 | $4.50 | Buy | Canaccord Genuity |
| 12/5/2023 | $3.25 | Buy | H.C. Wainwright |
Canaccord Genuity initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $4.50
H.C. Wainwright initiated coverage of ASP Isotopes with a rating of Buy and set a new price target of $3.25
WASHINGTON, D.C., July 25, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that the Company's proposed offer to acquire all of the issued ordinary shares of JSE-listed Renergen Limited ("Renergen") has been approved as of July 23, 2025, by the Competition Commission of South Africa, subject to certain conditions, which are acceptable to the Company. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of the
WASHINGTON, July 23, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), today announced the pricing of an underwritten registered direct offering of 7,500,000 shares of its common stock at a price of $8.00 per share to a single fundamental institutional investor. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $60.0 million. The offering is expected to close on or about July 25, 2025, subject to the satisfaction of customary closing conditions. Cantor and Canaccord Genuity acted as joint book-running managers for the offering. Ocean Wall Limited a
WASHINGTON, July 17, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced several updates on the progress of commercial production at the Company's three isotope enrichment facilities in Pretoria, South Africa as well as other corporate matters, in advance of a presentation by the Company's Chairman and CEO, Paul Mann, at the Emerging Growth Conference at 10:15 a.m. EST on July 17, 2025. Silicon-28. The Company commenced commercial production of Silicon-28 during late March 2025 and has
8-K - ASP Isotopes Inc. (0001921865) (Filer)
8-K - ASP Isotopes Inc. (0001921865) (Filer)
424B5 - ASP Isotopes Inc. (0001921865) (Filer)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
JOHANNESBURG, June 18, 2025 (GLOBE NEWSWIRE) -- Renergen is pleased to announce that preferred bidder status has been awarded to He4u consortium for the design, procurement, delivery, construction and commissioning for phase 2 of the Tetra4 LNG and helium liquefaction project, comprising of, Chart Industries Inc. (NYSE:GTLS), Wilson Bayly Holmes - Ovcon Ltd (JSE: WBO), and Aurex Constructors. The appointment of an acceptable EPC contractor in Phase 2 was one of the two remaining conditions for the DFC Phase 2 loan. The award is a key milestone in the project's progress. The award confirms that Chart Industries' Helium liquefier and LNG liquefaction technologies have been selected as Tet
WASHINGTON , June 11, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Dr. Ryno Pretorius, PhD as Chief Executive Officer of Quantum Leap Energy LLC (QLE), the Company's subsidiary that is pursuing an initiative to develop and commercialize advanced nuclear fuels, such as High Assay Low-Enriched Uranium (HALEU) and Lithium-6. Dr. Pretorius has previously served as a consultant to both ASP Isotopes and QLE. Paul Mann will continue to serve as the chairman and C
WASHINGTON, June 13, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced the appointment of Heather Kiessling as its chief financial officer (CFO), effective as of July 1, 2024 (or such earlier date as may be mutually agreed), to support the Company's next pivotal phase of growth. Robert Ainscow, who currently serves as the Company's CFO and chief operating officer (COO), will continue to serve as the Company's COO, enabling him to focus his full time and attention on the Company's operat
SC 13G - ASP Isotopes Inc. (0001921865) (Subject)
SC 13G/A - ASP Isotopes Inc. (0001921865) (Subject)
SC 13G - ASP Isotopes Inc. (0001921865) (Subject)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
4 - ASP Isotopes Inc. (0001921865) (Issuer)
ORLANDO, FL / ACCESSWIRE / September 13, 2024 / RedChip Companies will air interviews with Mobilicom Ltd. (NASDAQ:MOB) and ASP Isotopes Inc. (NASDAQ:ASPI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 14, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:Mobilicom: https://www.redchip.com/assets/access/mob_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessOren Elkayam, Founder and CEO of Mobilicom, appears on the RedChip Small Stocks, Big Money™ show on Bloomberg TV to provide a corporate update. Mobilicom presents a
ORLANDO, FL / ACCESSWIRE / May 24, 2024 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and Calidi Biotherapeutics Inc. (NYSE:CLDI) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, May 25, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:ASP Isotopes: https://www.redchip.com/assets/access/aspi_accessCalidi Biotherapeutics: https://www.redchip.com/assets/access/cldi_accessIn an exclusive interview, Paul Mann, CEO of ASP Isotopes, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to provide a corporate u
ORLANDO, FL / ACCESSWIRE / January 19, 2024 / RedChip Companies will air interviews with INNO Holdings, Inc. (NASDAQ:INHD) and ASP Isotopes, Inc. (NASDAQ:ASPI) on The RedChip Small Stocks Big Money® Show, a sponsored program on Bloomberg TV, this Saturday, January 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.Access the interviews in their entirety at:INNO Holdings: https://www.redchip.com/assets/access/inhd_accessASP Isotopes: https://www.redchip.com/assets/access/aspi_accessIn an exclusive interview, Alice Gong, COO of INNO Holdings, appears on the RedChip Small Stocks Big Money® Show on Bloomberg TV to provide a corporate update